The present application provides compounds, including all stereoisomers, solvates, prodrugs and pharmaceutically acceptable forms thereof according to Formula I ##STR00001## wherein R.sup.1a, R.sup.1b, R.sup.1c, Q, A, R.sup.3, W, D and R.sup.2 are defined herein. Additionally, the present application provides pharmaceutical compositions containing at least one compound according to Formula I and optionally at least one additional therapeutic agent. Finally, the present application provides methods for treating a patient suffering from an MCHR-1 modulated disease or disorder such as, for example, obesity, diabetes, depression or anxiety by administration of a therapeutically effective dose of a compound according to Formula I.

 
Web www.patentalert.com

< 9-aminomethyl substituted minocycline compounds

> Substituted indolizine 1,2,3,6,7,8 derivatives, FGFs inhibitors, a method for the preparation thereof and pharmaceutical compositions containing said derivatives

> 2-alkylbenzoxazole carboxamides as 5-HT.sub.3 modulators

~ 00529